chrisvoncsefalvay/vaers-outcomes huggingface dataset:
glucose was at 125; glucose was at 125; lot of stress lately; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75-year-old male patient received BNT162B2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) (Batch/Lot number: unknown) at the age of 75 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: METFORMIN. Vaccination history included: Bnt162b2 (dose 1), when the patient was 75 years old, for Covid-19 immunisation, reaction(s): "glucose levels are usually between "95-105", but now they have been around "130, 140, and 150"". The following information was reported: BLOOD GLUCOSE INCREASED (non-serious), CONDITION AGGRAVATED (non-serious), outcome "unknown" and all described as "glucose was at 125"; STRESS (non-serious), outcome "unknown", described as "lot of stress lately". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: He got the first dose of the Pfizer-BioNTech COVID-19 vaccine "on the 4th, and on the 7th " he "started getting rising numbers of [his] glucose in the morning". He mentioned his glucose levels are usually between "95-105", but now they have been around "130, 140, and 150". He explained his "old internist" mentioned to add "half a pill" when his glucose level rise, therefore instead of taking 2000 mg of Metformin/2 pills he has been taking 2500 mg. He added he received his second dose of the vaccine yesterday, and this morning his "glucose was at 125", but he said he still takes 2500 mg of Metformin. He asked could the vaccine cause a rise in the blood glucose level.  He then added he also had a "lot of stress lately", which could have also "caused" the higher blood sugar levels.    No follow-up attempts are possible; information on the lot/batch number cannot be obtained. No further information is expected.
Initial misuse report received from health care professional on 25 Oct 2013. It was reported that under age of 3 years patient had received 0.5 ml dose of FLUZONE instead of 0.25 as a first dose on an unspecified date. No adverse event was reported. List of documents held by sender: none.
Patient received improperly stored VARIVAX; No adverse event; This spontaneous report was received from medical assistant referring to a female patient of unknown age. The patient's concurrent conditions, drug allergies/reactions and medical history were not reported. On an unknown date, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (product storage error) (strength, formulation, dose/frequency, route was not reported) lot # S011951 expiration date reported as 16-APR-2019, but upon internal validation established as 16-APR-2021, for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. The vaccine was stored at a temperature of minus 12.3 degree Celsius for 6.05 hours. There was no previous temperature excursion. The call was because of data logger. No adverse effect was reported. The outcome of product storage error and no adverse event was unknown.
Injection arm was extremely sore with some swelling for 2-4 days after vaccine received.  Soreness continued for 2 weeks.
This is a spontaneous report from a Study Program -Pfizer for Professional Customer Support Line- for a contactable physician. A patient of unknown age, gender received PREVNAR 13 on an unknown date and COUMADIN since an unknown date at an unknown dose and frequency for an unknown indication. Relevant medical history and relevant concomitant medications of the patient were unknown. On 02May2013, while on warfarin sodium and after the administration of PREVNAR 13, INR test result was found very high at 16 (unknown units). Previously on 22Mar2013, the result of INR test was 2.7 (unknown units). Additionally, on 07May2013, while on warfarin sodium and after the administration of PREVNAR 13, the patient had conjunctival hemorrhage in eye, after which he/she was brought to the emergency room on an unspecified date in May2013. Last action taken with warfarin sodium was unknown. Therapeutic measures taken in response to the reported events were unknown. Clinical outcome of the reported events was unknown at the time of report.
Subsequent to receiving one dose of varicella virus vaccine live the pt was diagnosed with full blown chickenpox with over 35 lesions.
Patient fainted approximately 7 minutes after receiving the Covid-19 vaccine by pfizer. Patient fell to the floor from the bench he was sitting at. EMS was called and patient was talked into going to the  ER for observation.
SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 32 year old female. The patient's weight was 68.1 kilograms, and height was not reported. The patient's pre-existing medical conditions included patient had no medical history. The patient received covid-19 vaccine  (suspension for injection, intramuscular and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination on Right deltoid. No concomitant medications were reported. On 26-MAR-2021, the subject experienced suspected covid-19 infection. Laboratory data included:  rapid POC test (NR: not provided) Positive. The action taken with covid-19 vaccine was not applicable. The outcome of suspected covid-19 infection was not reported. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
This spontaneous report was received from a pharmacist referring to his wife, a 64 year old female patient. The patient had no pertinent medical history or drug reactions/allergies. Concomitant therapies included INDERAL, SINGULAIR, PREVACID and CENTRUM Performance (ginseng (+) ginkgo (+) minerals (unspecified)). On 11-AUG-2016, the patient was vaccinated with PNEUMOVAX 23 (unspecified strength and dose) lot # L026033 and expiration date 27-MAR-2017, via intramuscular, in the right arm. On 12-AUG-2016, the patient experienced pain under right breast; no treatment was received and pain began to subside on 14-AUG-2016, but was not entirely gone (recovering). The causality between the PNEUMOVAX 23 and the event was unknown. No product quality complaint (PQC) was involved. Additional information has been requested.
This child had a large area of erythema, induration, and some crusting at areas of excoriation from scratching. Patient was put on Prelone, Atarax (prn pruritis), and Bactroban.
Patient was vaccinated with Prevnar on 4/25/2001 and approximately 6 months later was diagnosed with type 1 diabetes.  Diabetes does not run in our family. 60-day follow up on 04/14/04: "Pt has not recovered from adverse events.  She is a type I (insulin dependant) diabetic." Medical records states weak, lethargic, polyuria, dehydration.
Approximately 15 min after vaccine was administered, patient experienced "disorientation and vision issues," no syncope occurred. She laid down and symptoms resolved. Patient unsure if related to actual vaccine or needle. Reports one previous episode of syncope with blood draw. The next day, the patient indicates feeling nauseated, unsure if related to vaccine.
FEVER; Erythema, edema to left upper arm, shoulder to elbow beginning morning after vaccine and progressing into next day; fever day one after vaccine.
The patient received the vaccine 22 days after the first shot. Spoke with mom, patient did not have any adverse effects from the vaccine.
Rapid heartbeat, flutter of heartbeat/rhythm, out of rhythm, rapid and strong heart patterns.
Patient was given the Twinrix which is the adult version 18 and older. She should have received the pediatric dose.
Patient just turned 12 and was given Pfizer Peds dose of 0.2 ml. No adverse reaction to the vaccine. No revaccination needed, but should have received adult dose.
Mild allergic reaction - very painful, red, itchy, warm and a small rash under the injection site started the day after the injection. Went to see doctor on 1/23 told me to take allergy medicine twice a day
p/vax pt exp sz;this case is considered medically serious;no tx given;most recent info recv 8/9/99 report sz lasted 60 seconds;
Information has been received from a pharmacist concerning her 67 year old husband who on 01-APR-2008 was vaccinated with zoster vaccine live (Oka/Merck). On 02-APR-2008 he developed redness and swelling at the injection site. Medical attention was not sought and there were no lab studies performed. At the time of the report the patient's symptoms were resolving without requiring treatment. There was no product quality complaint involved. Additional information has been requested. This is one of several reports from the same source.
Narrative: Patient received two doses of the covid vaccine and passed away 2 weeks after second dose. PMH includes diverticulosis, previous exposure to HBV (+HBcAb 2017, -HBsAg 2018), CKD IV, T2DM, HTN, HLD, BPH, and cirrhosis. Patient was transferred to home hospice given worsening condition. No other reports of cause of death noted. reporting due to instructions.
This spontaneous report as received from a physician through the patient's treating physician, refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with a dose of GARDASIL (lot number and expiration date not reported) (dose, frequency and route not reported). The reporting physician stated that on an unspecified date the patient developed seizures 1 month after receiving GARDASIL. It was unspecified if the patient sought medical attention and the patient received unspecified anti-seizure medications as treatment for seizures. At the time of the report the patient's outcome for seizures was unknown. Upon internal review the seizure was considered as other important medical event. Additional information has been requested.
Hoarseness, chills, fever, runny nose, fast heart rate. Rec'd shot 3:30 P. 8:30 P started chills, hoarseness, nose run. 9 P Fast heart. Hospital 11 PM. Admitted 5 AM.
Moderna covid-19 Vaccine  Extreme joint pain, chills, headache, stiff neck, dizziness, fatigue, eye pain. Treated with tylenol and tramadol. Symptoms very bad for 24 hours, then slowly disputed. These Flu like symptoms started about 6 hours after injection and lasted about 24 hours.
Approximately 6 hours after vaccination, I developed generalized malaise with significant pain in right arm (injection site), neck and back.  Over the subsequent 2-4  hours, I developed fever to 102.5 with shaking chills with ongoing myalgias and arthralgias (knees, hips).  I took some acetaminophen and fever eventually broke.  Still feeling weak, achy and fatigued but better.
12 hours after the injection, started to have increasing chills, then high fever reaching 101, and headache -- all of which lasted, on and off, for about 36 hours. Also had fatigue that lasted 3 days.
Fever pt reported 102F, body aches and arm pain at site of injection, fever decreased by morning.
I have a protruding vein connected from breast to stomach.; Lymph node under arms, on shoulder and neck. Now I have a protruding vein connected from breast to stomach.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 10:00 (Lot number: EWO175) at the age of 42 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "blood pressure" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 01May2021, outcome "not recovered", described as "Lymph node under arms, on shoulder and neck. Now I have a protruding vein connected from breast to stomach."; VASODILATATION (non-serious), outcome "unknown", described as "I have a protruding vein connected from breast to stomach.". The event "lymph node under arms, on shoulder and neck. now i have a protruding vein connected from breast to stomach." was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of lymphadenopathy.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received hydrochlorothiazide blood pressure medicine within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination.  No follow-up attempts are possible. No further information is expected.
upper respiratory infection; viral infection tested positive for strep infection; Initial information received on 08-Nov-2020 regarding an unsolicited valid serious case from a consumer/non-health care professional via social media.  This case involves a patient (unknown demographics) who developed an upper respiratory infection (upper respiratory tract infection) and tested positive for strep. infection (streptococcal infection), after receiving INFLUENZA VACCINE.  Concomitant medications and family history were not provided.  At the time of the event, the patient had ongoing medical history of allergy to raw eggs.  On an unknown date in 1995, the patient received first dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious events of an upper respiratory infection (upper respiratory tract infection) and viral infection tested positive for strep infection and could not work for 2 weeks (streptococcal infection), (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for these reported events on an unknown date.  The patient also received the shot this year for the first time with the pneumonia shot and was good.  Other relevant laboratory data was not reported.  It was not reported if the patient was receiving any corrective treatment.  At the time of reporting, the outcome was not reported for both the events.  Information on the batch number to be requested.; Sender's Comments: This poorly documented social media case concerns a patient of unknown demographics who had upper respiratory tract infection and streptococcal infection, after vaccination with INFLUENZA VACCINE. Time to onset is unknown. The patient was allergic to raw eggs. Moreover, patient's other medical condition at the time of vaccination, concomitant medication and family history were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Patient received 2 vaccines in Left arm. MENACTRA/BEXSERO at 16 yr visit. Pt. came in a week later complaining of muscle pain and unable to lift her arm that vaccines were given in. Per physician: Tender to palpation just inferior to tip of shoulder and over deltoid muscle. Slightly warm, not red or swollen. Can actively abduct past 90 degrees then starts to use neck muscles.
Found unconscious with fever of 103. Once awoke, vomitting and diarrhea. Fever continued for 48 hours with vomiting.
Nausea, headache, body aches and pains, fever of 100.7 orally and chills, chest pain,  feeling of burning at surgical scar site, malaise starting around 18 hours post injection and lasting about 14 hours. Minimal to zero relief with Ibuprophen, or Acetaminophen. No medical treatment required.  Headache continues to persist but chronic headaches are part of normal history.
Disruption in menstrual cycle. For 3 cycles following vaccination, my menstrual cycle was shorter by 2 days for the first 2 months then 3 days for the third month.
About 15-20 minutes after getting vaccine began having difficulty breathing, tightness in chest and throat, numbness/tingling in hands and feet. Went home and around 9:00 my heart began to race and began having more difficulty breathing. Also began experiencing itching and low grade temp. During the night began having chest pains. Called PCP in the morning and was told to go to ER. ER monitored my heart rate and breathing. Administered breathing treatment and the symptoms improved. Had to return to urgent care October 13th. They prescribed albuterol to help with chest pain and tightness.
Started 2/6/21 at approximately 8pm and lasted for 5 days: Extreme weekness, light headed, nausea,  migrains, burning in eyes, chills, rampted up back pain, extreme pain in left arm, unable to sleep.
On 04/15/2022 - I received 4th booster shot. On November 15/2021 I started having headache , and nausea but it was not every day. Sometimes I get light headache. After the 4th booster shot- headache, nausea , fever, imbalance . I started having that for 8-9 days non stop. and I went to the doctor on the 8th day. After I went to the doctor headache came and went. I lost balance and i still have it now. Now I am scared of walking i feel like I will fall and break my bones. I still have the headache it comes and goes. 05/05/2022 i will be going to do MRI for my brain. I will take appointment for a neurologist. I got all this from the 4th booster not sure exactly what's going on but i will find out.
Presyncopal episode S/S pallor, diaphoretic about 6 mins. after vaccine - gave cold H2O. Pt was sitting, took BP 114/48, P.84, RR 12. Cool pack to back of neck, assisted to couch and put feet up then BP taken again approximately 12 min. after episode BP 121/68, P. 87, RR 14. Pt. stayed in office then released with Mom after 30 minutes. Mom was called at 2 PM to follow up on patient, Mom reports patient okay.
Persistent pain in (L) mid upper arm 6 months after injection. Tender. Subsequently developed impingement syndrome of shoulder, but tenderness out of proportion to expected referred pain.
Pt had a macular rash over left arm that appeared on body in 2-3 minutes/not papular.
Arm pain during injection/ arm pain is now a few inches from injection site shooting to hand; Unable to move arm without severe pain; Knot is forming a few inches away from injection site; Arm pain is now a few inches from injection site shooting to hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain during injection/ arm pain is now a few inches from injection site shooting to hand), PAIN (Unable to move arm without severe pain), VACCINATION SITE MASS (Knot is forming a few inches away from injection site) and VACCINATION SITE PAIN (Arm pain is now a few inches from injection site shooting to hand) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain during injection/ arm pain is now a few inches from injection site shooting to hand), PAIN (Unable to move arm without severe pain), VACCINATION SITE MASS (Knot is forming a few inches away from injection site) and VACCINATION SITE PAIN (Arm pain is now a few inches from injection site shooting to hand). At the time of the report, PAIN IN EXTREMITY (Arm pain during injection/ arm pain is now a few inches from injection site shooting to hand), PAIN (Unable to move arm without severe pain), VACCINATION SITE MASS (Knot is forming a few inches away from injection site) and VACCINATION SITE PAIN (Arm pain is now a few inches from injection site shooting to hand) outcome was unknown. Unknown          No relevant concomitant medications were reported. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.
heavy feeling in her chest; The top right quadrant of her right breast hardened and it was "incredibly painful" for her; The top right quadrant of her right breast hardened and it was "incredibly painful" for her; fever (102F); chills; fatigue; joint and muscle pain; joint and muscle pain; swelling of the lymph nodes; she felt intoxicated/drugged up; she felt intoxicated/drugged up; watery effect on her right eye; pain in her lower leg; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided) solution for injection, via an unspecified route of administration on 11Feb2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got her first dose of COVID-19 vaccine on Thursday, 11Feb2021. Immediately, she felt intoxicated/drugged up and had a watery effect on her right eye. When she got home, she experienced pain in her lower leg. The next day, 12Feb2021, she experienced fever of 102 Fahrenheit, chills, fatigue, joint and muscle pain, and swelling of lymph nodes. On Sunday, 14Feb2021, she had a heavy feeling in her chest. The top right quadrant of her right breast hardened, and it was incredibly painful for her. She said everything has been resolved except for her breast. She has spoken with her 2 doctors and asked her to contact Pfizer for her adverse events. She wanted to know if what she was experiencing was normal and wanted to know the recommendation for the second dose of the vaccine. The outcome of the events breast induration and breast pain was not recovered and recovered on Feb2021 for all other events.   Information on the lot/batch number has been requested.
Patient started feeling like she had cotton mouth and felt very nauseous, so we gave her water. She then felt like her throat was getting tight so we administered 25mg diphenhydramine, followed by a second 25mg diphenhydramine capsule a few minutes later. At this point the patient started getting hives on the back of her neck. We gave her an ice pack and called 911. The paramedics assessed her at this point and determined she did not need to go to the hospital. They advised the gentleman with her to keep an eye on her and to immediately go to the ER or call 911 if her symptoms worsened at all.
blue patches on skin within a few days of the first or second dose  diagnosed thrombocytopenia
A non-serious spontaneous report of administration of expired vaccine was received from a health professional concerning approximately 14 children. Neither relevant medical history nor concomitant medications had been reported for these patients. The product expired in Jan-2011. On 23-Sep-2011, the patients received the expired product. There were no adverse events associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
24hr after PCV-13 vaccination developed fine discrete barely perceptible macular pimp/rash on (L) thigh around inj. site. ROS negative 1st dose of PCV13. Prev had PC7 as #1.